Company Name

Overview

This is a cautionary note from Part I of the company's Form 10-K addressing forward-looking statements. The section references activities the company may pursue, including acquisitions, clinical trials, product approvals and launches, intellectual property, regulatory and tax matters, and macroeconomic and geopolitical considerations.

Topics covered by the forward-looking statements

• Financial and operating performance
• Acquisitions
• Clinical trials and market studies
• Business plans and product performance
• New and anticipated product approvals and launches
• Intellectual property and regulatory matters
• Legal proceedings, tax matters, and regulations
• Macro and geopolitical conditions

Basis and risk

• These statements reflect the company’s beliefs, assumptions, and estimates at the time they were made.
• They are not guarantees of future results.
• If assumptions prove incorrect or risks materialize, actual results may differ materially from expectations.

General guidance for readers

• Do not place undue reliance on forward-looking statements.
• Risk factors described in Part I, Item 1A (Risk Factors) and elsewhere in the report could affect outcomes.

Risks and uncertainties (examples)

• Economic conditions and foreign currency fluctuations
• U.S. and global political, regulatory, reimbursement, and trade conditions
• Geopolitical events and tensions
• Manufacturing, distribution, supply chain disruptions, and cost increases
• Cybersecurity incidents and operational disruptions
• Public health emergencies, extreme weather, and climate change impacts
• Labor shortages and rising labor costs
• Variability in clinical trial outcomes and market studies
• Market competition and pricing pressures
• Expected procedural volumes and market adoption of products
• Closing and integration of acquisitions
• Demographic trends and intellectual property rights
• Litigation and financial market conditions
• Effects of restructuring, strategy execution, and sustainability initiatives
• Other risks and uncertainties; new risks may develop over time

Where to find more details

See Part I, Item 1A, Risk Factors for the specific risk descriptions and any updates related to forward-looking statements.